Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
The American Journal of Cardiology
|
October 7, 1997
Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction
C P Cannon, P J Sharis, M J Schweiger, et al.
The New England Journal of Medicine
|
December 3, 1998
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators
M B Leon, D S Baim, J J Popma, et al.
Gynecologic Oncology
|
August 24, 2020
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit
Michael T Richardson, David P Mysona, David A Klein, et al.
Journal of the American College of Cardiology
|
September 14, 1999
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry
D E Cutlip, M B Leon, K K Ho, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
November 11, 2025
Heterogeneity and Scoring Reproducibility of Folate Receptor 1 Immunohistochemistry in High-grade Serous Carcinoma
Brooke Liang, Troy B Tenney, Lucy Han, et al.
Journal of the American College of Cardiology
|
July 1, 1997
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia
C P Cannon, C H McCabe, P H Stone, et al.
JAMA
|
April 10, 1996
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry
P H Stone, B Thompson, H V Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2024
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
A Alvarez Secord, S N Lewin, C G Murphy, et al.
Circulation
|
August 2, 2000
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study
P J Fitzgerald, A Oshima, M Hayase, et al.
The Lancet. Oncology
|
April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial
Toon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
The American Journal of Cardiology
|
October 7, 1997
Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction
C P Cannon, P J Sharis, M J Schweiger, et al.
The New England Journal of Medicine
|
December 3, 1998
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators
M B Leon, D S Baim, J J Popma, et al.
Gynecologic Oncology
|
August 24, 2020
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit
Michael T Richardson, David P Mysona, David A Klein, et al.
Journal of the American College of Cardiology
|
September 14, 1999
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry
D E Cutlip, M B Leon, K K Ho, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
November 11, 2025
Heterogeneity and Scoring Reproducibility of Folate Receptor 1 Immunohistochemistry in High-grade Serous Carcinoma
Brooke Liang, Troy B Tenney, Lucy Han, et al.
Journal of the American College of Cardiology
|
July 1, 1997
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia
C P Cannon, C H McCabe, P H Stone, et al.
JAMA
|
April 10, 1996
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry
P H Stone, B Thompson, H V Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2024
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
A Alvarez Secord, S N Lewin, C G Murphy, et al.
Circulation
|
August 2, 2000
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study
P J Fitzgerald, A Oshima, M Hayase, et al.
The Lancet. Oncology
|
April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial
Toon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Page
of 13